Acute Flaccid Myelitis Update

The latest update on acute flaccid myelitis, including case counts.

Breaking News – The CDC has updated the Acute Flaccid Myelitis (AFM) case counts. (see below).

These 223 confirmed cases are among the total of 374 reports that CDC received of patients under investigation.

We continue to get regular updates from the CDC about AFM.

CDC Telebriefing: Update on Acute Flaccid Myelitis (AFM) in the U.S.

Unfortunately, we aren’t getting the real answer we were looking for – how to stop the outbreak.

Acute Flaccid Myelitis Update

Since the last update, we have learned that:

  • the case count is up to 223 confirmed cases among 374 reports, with most cases being confirmed at this point (2018)
  • cases have been reported in 41 states (2018)
  • there have been 2 confirmed cases (NC and UT) among 15 reported cases so far this year (2019)

That means that we have clearly exceeded the last record of 149 cases in 2016.

There are also 49 confirmed cases and 28 cases under investigation in Canada since January 2018.

In other news:

  • the CSTE will be issuing issued a new statement on AFM reporting reaffirming that they “are confident state and local health departments are working closely with doctors to ensure suspected cases are reported.”
  • the CDC has posted updated treatment guidelines
  • an MMWR early release, Increase in Acute Flaccid Myelitis — United States, 2018,  will provide details on the first 80 cases of 2018 – but sound similar to what we have learned from outbreaks in 2014 and 2016…
  • the CDC is working with local and state health departments on better long term tracking of cases – something parents have been pushing for!
  • an AFM Task Force has been established to “bring together experts from a variety of scientific, medical, and public health disciplines to help solve this critical public health issue.”

Most importantly though, we again learned that the CDC still doesn’t feel that they have enough evidence to say that any one thing is causing AFM.

AFM Cases in the United States

In addition to this year’s cases, there were:

  • 33 confirmed cases in 16 states in 2017
  • 149 confirmed cases in 39 states in 2016
  • 22 confirmed cases in 17 states in 2015
  • 120 confirmed cases in 34 states in 2014 – with most of the cases being reported in California (24), Colorado (10), Utah (6), Massachusetts (9), Virginia (5), Indiana (5), and Illinois (4)

What’s next?

More on Acute Flaccid Myelitis News

Updated on March 27, 2019

The Case for Making AFM Reporting Mandatory

Do we really need to add AFM to the Nationally Notifiable Condition List? Will that mean mandatory reporting of all cases?

There have been 158 cases of acute flaccid myelitis (AFM) so far this year, with another 153 cases under investigation by the CDC and state and local health departments.

“Acute flaccid myelitis (AFM) is not nationally notifiable; CDC relies on clinician recognition and health department reporting of patients under investigation (PUIs) for AFM to learn more about AFM and what causes it.”

But could there be more cases?

The Case for Making AFM Reporting Mandatory

Although AFM isn’t yet a nationally notifiable disease,  120 other diseases are, from Anthrax and Botulism to Vibriosis and Zika virus disease.

The Nationally Reportable Disease List depends on state laws for any mandate to report.
The Nationally Notifiable Condition List depends on state laws for any mandate to report.

Who picks them?

The Council of State and Territorial Epidemiologists.

“Although AFP surveillance is commonly conducted in many countries currently still at risk for ongoing transmission of poliovirus, AFP is not a reportable condition in any U.S. state and routine surveillance and assessment for AFP is not performed. Therefore, understanding the baseline incidence and epidemiology of AFM and its public health impact in the United States is significantly limited.”

Revision to the Standardized Surveillance and Case Definition for Acute Flaccid Myelitis

Acute flaccid paralysis (AFP) isn’t a reportable disease in the United States either.

While many people would like AFM to be added to the the Nationally Notifiable Condition List, the CSTE has instead recommended that we:

  1. Utilize standard sources (e.g. reporting to a local or state public health department) for case ascertainment for acute flaccid myelitis (AFM), including clinician and laboratory reporting, reporting by hospitals, hospital discharge notes, neurology or infectious disease consult notes, MRI reports and images, outpatient records, and extracts from electronic medical records, etc.
  2. Utilize standardized criteria for case identification and classification for acute flaccid myelitis (AFM) but do not add AFM to the Nationally Notifiable Condition List . If requested by CDC, jurisdictions (e.g. States and Territories) conducting surveillance according to these methods may submit case information to CDC.
  3. Report cases as soon as possible and continue surveillance.
  4. Share data to “measure the burden of acute flaccid myelitis (AFM).”

And the CDC has agreed.

“CDC concurs with this position statement. We look forward to continuing to work with our jurisdictional partners to address this important public health issue. This standardized case definition provides an opportunity to better define the spectrum of illness seen with AFM and to determine baseline rates of AFM in the United States. During review of the position statement, a few minor edits were identified as necessary for clarification, and we are working with the author to make these changes.”

What would be the difference if AFM was added to the Nationally Notifiable Condition List?

For one thing, because the list of reportable conditions varies from state to state, it would provide a uniform case surveillance and case definition.

But we already have that in the CSTE Position Statement on Acute Flaccid Myelitis.

The big issue is that there is no federal law that actually mandates reporting for the diseases on the list! Or even to report them to the CDC.

“Each state has laws requiring certain diseases be reported at the state level, but it is voluntary for states to provide information or notifications to CDC at the federal level.”

CDC on Data Collection and Reporting

It is up to state laws – in each and every state.

“The legal basis for disease reporting is found at the state level, where inconsistent laws may differ in terms of which conditions are reportable and their reporting process.”

Brian Labus on Differences In Disease Reporting: An Analysis Of State Reportable Conditions And Their Relationship To The Nationally Notifiable Conditions List

So even if the Council of State and Territorial Epidemiologists added AFM to the Nationally Notifiable Condition List, you would then need each state to pass a law adding AFM to their lists of notifiable diseases.

“Currently AFM is not a reportable condition in Texas.”

TxDSHS on Acute Flaccid Myelitis

How long would that take?

Zika is on the Nationally Notifiable Condition List, but guess what, like AFM, it isn’t on the reportable condition list in many states…

Utah has already added AFM to its list of notifiable conditions. Has your state?
Utah, Washington and Colorado have already added AFM to their list of notifiable conditions. Has your state?

Want to get more cases of AFM reported to the CDC?

Let’s raise awareness about AFM and educate parents and health professionals to get all cases diagnosed, as they can then get reported to local and state health departments, who will then report them to the CDC.

Making AFM reporting mandatory might sound like a big deal, but will it really make any difference in getting kids diagnosed and treated?

“Ultimately, we would have to decide what the purpose of making something nationally notifiable is. We can investigate it just as well without that designation, and keeping things at the state level (for now) allows a lot more flexibility in how we define and investigate it. It might seem frustrating because it isn’t on the nationally-notifiable list, but that honestly doesn’t matter in terms of how we investigate things.”

Brian Labus, PhD, MPH

Cases still get investigated without being on the Nationally Notifiable Condition List.

Cases still get reported without being on the Nationally Notifiable Condition List.

And that’s good, because adding AFM to the Nationally Notifiable Condition List is not something that would happen overnight.

CP-CRE was added to the National Notifiable Disease List in 2018 at the 2017 CSTE annual meeting.
CP-CRE was added to the National Notifiable Condition List in 2018 at the 2017 CSTE annual meeting.

The CSTE would probably discuss it at their next meeting (next summer), and if approved, it would take effect at the beginning of the new year – January 2020. But then, then CDC has to get approval from the Office of Management and Budget (OMB) to actually get permission to start collecting the data on AFM for the Nationally Notifiable Condition List. All of that likely means that the earliest we would see “national” reporting for AFM would be sometime in 2022.

Does that mean we should jump on it now if it is going to take so long, or should we wait to figure out a definitive cause, and then put that on the Nationally Notifiable Condition List?

Whatever we do, remember that it still wouldn’t be mandated reporting unless each and every state actually passes a law mandating reporting of AFM cases to the CDC. Again, being on the Nationally Notifiable Condition List simply means that states are strongly encouraged to report their cases, as they do now. There are several diseases on the Nationally Notifiable Condition List that states never add to their own notifiable conditions list.

“It is voluntary that notifiable disease cases be reported to CDC by state and territorial jurisdictions (without direct personal identifiers) for nationwide aggregation and monitoring of disease data. Regular, frequent, timely information on individual cases is considered necessary to monitor disease trends, identify populations or geographic areas at high risk, formulate and assess prevention and control strategies, and formulate public health policies. The list of notifiable diseases varies over time and by state. The list of national notifiable diseases is reviewed and modified annually by the CSTE and CDC. Every national notifiable disease is not necessarily reportable in each state. In addition, not every state reportable condition is national notifiable.”

CDC on Data Collection and Reporting

Mostly, folks should understand that simply being on the Nationally Notifiable Condition List may not mean as much as they think it does.

“Although disease and condition reporting is mandated at the state, territory, and local levels by legislation or regulation, state and territory notification to CDC is voluntary. All U.S. state health departments, five territorial health departments, and two local health departments (New York City and District of Columbia) voluntarily notify CDC about national notifiable diseases and conditions that are reportable in their jurisdictions; the data in the case notifications that CDC receives are collected by staff working on reportable disease and condition surveillance systems in local, state, and territorial health departments.”

CDC on Data Collection and Reporting

And that epidemiologists at the local, state, and national level are working hard to identify all cases of AFM, which will hopefully help them figure out what is causing these cases, how to treat kids who are already affected, and how to prevent new cases.

They are identifying more and more cases of AFM even though few states have mandatory reporting, AFM isn’t on the Nationally Notifiable Condition List, and reporting of cases to the CDC is voluntary.

More on Making AFM Reporting Mandatory

Updated on December 10, 2018

%d